![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Alzheimer's Disease |
|
Free Subscription
2 Acta Neuropathol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
Frequency of mixed neuropathologies in individuals with down syndrome with and
without Alzheimer's dementia.
Acta Neuropathol. 2026;151:55.
PubMed
Abstract available
A plasma protein signature for cerebral amyloid angiopathy.
Acta Neuropathol. 2026;151:59.
PubMed
Abstract available
Depression and Anxiety in Stroke-Related and Alzheimer Disease-Related
Pseudobulbar Affect: A TriNetX Retrospective Cohort Study.
Alzheimer Dis Assoc Disord. 2026 May 15. doi: 10.1097/WAD.0000000000000727.
PubMed
Abstract available
Complex interplay of astrogliosis and pathology in preclinical Alzheimer's
disease.
Alzheimers Dement. 2026;22:e71520.
PubMed
Abstract available
Letter to the editor response for: "Schneider LS, Kennedy RE, Cutter G. Caution
in interpreting disease-modification claims with lecanemab: selective reporting
and causal inference. Alzheimer's & Dementia. 2026".
Alzheimers Dement. 2026;22:e71485.
PubMed
Uncovering distinct spatiotemporal trajectories of T-N mismatch subtypes with
likely co-pathology in Alzheimer's disease using event-based modeling.
Alzheimers Dement. 2026;22:e71474.
PubMed
Abstract available
Age-related behavioral and molecular landmarks in new mouse models for studying
Alzheimer's disease in Down syndrome.
Alzheimers Dement. 2026;22:e71498.
PubMed
Abstract available
2-aminobutyrate mediates the impact of air pollution on blood biomarkers of
Alzheimer's disease.
Alzheimers Dement. 2026;22:e71388.
PubMed
Abstract available
Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease
and Parkinson's disease using polygenic risk scores and Mendelian randomization.
Alzheimers Dement. 2026;22:e71469.
PubMed
Abstract available
Circulatory pro-CTSD binds brain endothelial LRP1 to trigger its lysosomal
degradation leading to amyloid beta clearance deficit in Alzheimer's disease
mice.
Alzheimers Dement. 2026;22:e71494.
PubMed
Abstract available
Native PLGA nanoparticles attenuate disease pathology via multiple pathways in
5xFAD Alzheimer's model.
Alzheimers Dement. 2026;22:e71348.
PubMed
Abstract available
Reciprocal molecular and cellular cholinergic working memory impairments in
Alzheimer's disease model mice.
Alzheimers Dement. 2026;22:e71490.
PubMed
Abstract available
Non-linear associations between sleep duration and plasma p-tau181 in the
Framingham Heart Study.
Alzheimers Dement. 2026;22:e71499.
PubMed
Abstract available
Remote, unsupervised assessment of cognitive impairment and decline in
Alzheimer's disease using the Cogstate Brief Battery in ADNI-3.
Alzheimers Dement. 2026;22:e71357.
PubMed
Abstract available
Physical activity, aerobic fitness, and AD blood biomarkers: The IGNITE study.
Alzheimers Dement. 2026;22:e71484.
PubMed
Abstract available
Speech-based digital cognitive assessment for clinical trials: Detecting
cognitive impairment stages and AD biomarker relations across European cohorts.
Alzheimers Dement. 2026;22:e71462.
PubMed
Abstract available
Reconstructing cerebral lymphatic clearance: an emerging target in the
Alzheimer's disease therapeutic pipeline.
Alzheimers Dement. 2026;22:e71451.
PubMed
Abstract available
Neurovascular-metabolic dysregulation, metabolic connectomics, and metabolic
functional changes in Alzheimer's disease: A preclinical and clinical comparison.
Alzheimers Dement. 2026;22:e71496.
PubMed
Abstract available
Elevated AD biomarkers do not explain cognitive performance in a
community-recruited clinical trial cohort.
Alzheimers Dement. 2026;22:e71472.
PubMed
Abstract available
Cognitive dispersion profiles and prediction of cognitive change in early-onset
dementias: Results from LEADS.
Alzheimers Dement. 2026;22:e71492.
PubMed
Abstract available
How does type 2 diabetes modify the risk of Alzheimer's disease?
Alzheimers Dement. 2026;22:e71471.
PubMed
Abstract available
Unawareness of deficits in mild cognitive impairment: a systematic review of its
role in progression to Alzheimer's disease.
BMC Neurol. 2026 May 20. doi: 10.1186/s12883-026-04884.
PubMed
Abstract available
Exploring the Mechanism of Saponins from Panax japonicus in Improving Alzheimer's
Disease Based on Network Pharmacology and Molecular Docking.
Curr Alzheimer Res. 2026 May 9. doi: 10.2174/0115672050471394260327075445.
PubMed
Abstract available
Trends in Cerebrovascular Disease Mortality Among Alzheimer Patients in Older
Adults Across the USA: A CDC Wonder Analysis.
Curr Alzheimer Res. 2026 May 18. doi: 10.2174/0115672050429545260402050204.
PubMed
Abstract available
Knowledge, attitude, and practice toward Alzheimer's disease prevention among
middle-aged and elderly individuals: a cross-sectional study.
Dement Geriatr Cogn Disord. 2026 May 16:1-24. doi: 10.1159/000552507.
PubMed
Abstract available
Microglial senescence and epigenetic reprogramming in alzheimer's disease: An
immunometabolic perspective.
Exp Gerontol. 2026 May 16:113177. doi: 10.1016/j.exger.2026.113177.
PubMed
Abstract available
Kallikrein-8 contributes to kallikrein-kinin system dysregulation in Alzheimer's
disease.
Exp Neurol. 2026;403:115834.
PubMed
Abstract available
An aging hallmark, Alzheimer's disease, and APOE nexus.
J Alzheimers Dis. 2026 May 21:13872877261452598. doi: 10.1177/13872877261452598.
PubMed
Abstract available
(Alzheimer's) dementia in adults with Down syndrome in Germany: Administrative
prevalence based on a claims data analysis.
J Alzheimers Dis. 2026 May 15:13872877261449417. doi: 10.1177/13872877261449417.
PubMed
Abstract available
Inflammation-related miR-155-5p as an APOE epsilon4-modulated biomarker for amyloid
pathology in mild cognitive impairment.
J Alzheimers Dis. 2026;111:878-889.
PubMed
Abstract available
Eye movement features are associated with cognitive and mobility decline.
J Alzheimers Dis. 2026;111:782-791.
PubMed
Abstract available
Predictors of long-term care admission in a rural and remote memory clinic.
J Alzheimers Dis. 2026;111:592-599.
PubMed
Abstract available
A systematic review on the effects of hypercaloric diet in animal models of
Alzheimer's disease.
J Alzheimers Dis. 2026 May 22:13872877261448495. doi: 10.1177/13872877261448495.
PubMed
Abstract available
A High-Throughput Assay for Monitoring and Quantifying Amyloid-beta Accumulation and
Clearance in Alzheimer's Disease Cell Models.
J Neurochem. 2026;170:e70473.
PubMed
Abstract available
Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain
and transthyretin amyloidosis.
Nat Med. 2026;32:1676-1681.
PubMed
Abstract available
The exposome of brain aging across 34 countries.
Nat Med. 2026;32:1838-1851.
PubMed
Abstract available
Spatial proteomic analysis in human Alzheimer's disease brains enables
identification of microenvironment-dependent microglial cell states.
Nat Neurosci. 2026 May 18. doi: 10.1038/s41593-026-02267.
PubMed
Abstract available
Relation of blood-based inflammation conditional networks to key immune health
status and Alzheimer's biomarkers in aging adults.
Neurobiol Aging. 2026;166:14-28.
PubMed
Abstract available
Predicted brain-regional gene expression patterns in individuals living with
Alzheimer's disease.
Neurobiol Aging. 2026;166:29-40.
PubMed
Abstract available
Cellular- and systems-level profiling of amyloid-beta effects on circadian
timing.
Neurobiol Dis. 2026;224:107389.
PubMed
Abstract available
beta-Asarone, Tenuifolin, and YuanZhi Decoction Restore Cognitive Function and
Modulate GRIN2B-Associated Autophagy in Alzheimer's Disease.
Neurochem Res. 2026;51:170.
PubMed
Abstract available
Alkaloids from Dendrobium Nobile Lindl Improves Mitochondrial Function by
Enhancing the Activity of v-ATPase in APP/PS1 Mice.
Neurochem Res. 2026;51:171.
PubMed
Abstract available
Indoleamine 2,3-dioxygenase 1 (IDO1) promoted the activation of inflammatory
response in the brain tissue of Alzheimer's disease mice by regulating NF-kappaB
pathway.
Neurosci Lett. 2026 May 19:138635. doi: 10.1016/j.neulet.2026.138635.
PubMed
Abstract available
DTI-ALPS index and its association with neuroinflammatory and neurodegenerative
biomarkers and tau-PET in Alzheimer's continuum.
Neuroscience. 2026 May 20:S0306-4522(26)00313.
PubMed
Abstract available
A hybrid CNN-GCN framework for interpretable Alzheimer's disease diagnosis from
MRI scans.
Neuroscience. 2026 May 20:S0306-4522(26)00328.
PubMed
Abstract available
TDP-43: a critical amplifier of Alzheimer's disease beyond amyloid and tau.
Neuroscience. 2026 May 20:S0306-4522(26)00341.
PubMed
Abstract available
Facilitating the measurement and treatment of Behavioral and Psychological
Symptoms of Dementia (BPSD) and understanding caregiver burden using wearable
devices in Rural Taiwan-Protocol for a dyadic feasibility pilot study.
PLoS One. 2026;21:e0342136.
PubMed
Abstract available
Editorial Note: Zileuton Improves Memory Deficits, Amyloid and Tau Pathology in a
Mouse Model of Alzheimer's Disease with Plaques and Tangles.
PLoS One. 2026;21:e0349725.
PubMed
Memory and thinking problems that aging Latinos in New York City would bring to a
doctor's attention.
PLoS One. 2026;21:e0349635.
PubMed
Abstract available
Prediction of cognitive impairment through speech data analysis: A comparative
evaluation of deep learning models.
PLoS One. 2026;21:e0349412.
PubMed
Abstract available
PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive
decline in a familial Alzheimer's disease model.
Proc Natl Acad Sci U S A. 2026;123:e2525028123.
PubMed
Abstract available
Thank you for your interest in scientific medicine.